The Water Drinking Test in Glaucoma Study

Glaucoma Clinical Trial

— WIGS  

Official title:

The Water Drinking Test in Glaucoma Study

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05283031
• Other study ID #: 19IC5525
• Status: Recruiting
• Start date: March 12, 2021
• Est. completion date: September 30, 2022

Study information

• Verified date: March 2022
• Source: Imperial College London
• Contact: Jamie Spofforth
• Phone: +44 (0)20 3312 3206
• Email: Jamiespofforth[@]nhs.net
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

To investigate the correlation and agreement between the intraocular pressure peaks detected during the water drinking test and modified diurnal tension curve in glaucomatous eyes and to analyse whether this is associated with prognostic outcome. The study will also measure autonomic nervous system activation during the test to investigate one possible mechanism behind it.

Description:

Glaucoma is a progressive optic neuropathy characterized by progressive loss of retinal ganglion cells, leading to thinning of the retinal nerve fiber layer and visual field losses. It is the leading cause of irreversible blindness in the world [2] and affects more than 70 million people worldwide. Intraocular pressure (IOP) is the main risk factor for the development and progression of glaucoma. The gold standard for intraocular pressure (IOP) measurement is applanation tonometry. Routine office measurements may not detect IOP peaks in roughly 30% of patients due to variation throughout the day and this detection failure may be responsible for visual field progression in apparently well-controlled patients. Therefore this study is to investigate the correlation and agreement between the intraocular pressure peaks detected during the water drinking test and modified diurnal tension curve in glaucomatous eyes and to analyze whether this is associated with prognostic outcome. The study will also measure autonomic nervous system activation during the test to investigate one possible mechanism behind it. The primary measure is peak Intraocular pressure measurements from two different measures. Secondary measures include OCT angiography, postural blood pressure, heart rate, pupil diameter. Current and future rates of progression using visual field and optical coherence tomography (OCT) measures. This is a prospective method comparison study, of 40 primary open angle and normal tension glaucoma patients who will attend for a single visit. Inclusion criteria include those

• Able to give informed consent to participate in the study

• Aged between 40 and 80 years of age

• Clear optical media

• Spherical equivalent +-10 Dioptres

• Normal tension glaucoma proven by visual field testing or OCT imaging combined with clinical assessment.

• Primary open angle glaucoma proven by visual field testing or OCT imaging combined with clinical assessment

Following completion of the study, participants will be followed up in their usual clinic as part of their regular care. The participants' follow-up data which is routinely generated as part of the glaucoma care pathway will be accessed for 18 months following completion of participation with a view of correlating initial results with possible disease progression and other related outcomes.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 40
• Est. completion date: September 30, 2022
• Est. primary completion date: September 30, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• Able to give informed consent to participate in the study

• Aged between 40 and 80 years of age

• Clear optical media

• Spherical equivalent +-10 Dioptres

• Normal tension glaucoma proven by visual field testing or OCT imaging combined with clinical assessment.

• Primary open angle glaucoma proven by visual field testing or OCT imaging combined with clinical assessment.

Exclusion Criteria:

• Are using ocular hypotensive therapy, or have done so in the last 30 days

• Have any other known ocular disease (except glaucoma)

• Have serious cardiac or kidney disease (WDT contra-indication)

• Have swallowing difficulties associated with either a neurological or gastrointestinal condition.

• Patients with any contra-indication of drinking large amounts of water in a small period of time e.g. swallowing impairment, oesophageal stricture, gastric banding.

• Have secondary or narrow/closed angle glaucoma

• Patients submitted to any surgical procedure or laser intervention during the evaluation period

Related Conditions & MeSH terms

• Glaucoma

Intervention

Diagnostic Test:
• Modified Diurnal Tension Curve
The modified diurnal tension curve (mDTC), an alternative that involves IOP measurements every 2 or 3 hours during office hours, is more feasible and may provide better information regarding the IOP profile than single IOP measurements.

Locations

Country	Name	City	State
United Kingdom	Imperial College Ophthalmic Research Group	London

Sponsors (1)

Lead Sponsor	Collaborator
Imperial College London

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Peak Intraocular Pressure measurements from the two different methods	The modified diurnal tension curve is a test that consists of four to five eye pressure measurements taken through out office hours to check for rises in pressure that may be missed during their clinic appointment.	Baseline assessment on one day during office hours